Facing political pressure, Sanofi follows Eli Lilly and Novo Nordisk in slashing insulin prices

Hits: 19

The French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts.  Read More Go To Source

Be the first to comment

Leave a Reply

Your email address will not be published.


13 − two =